Posted inStock
China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
(Reuters) – Eli Lilly (NYSE:LLY) and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients lose weight while preserving muscle, the biotech said…